To view or add a comment, sign in First-pass metabolism (also called first-pass effect) is a pharmacokinetic phenomenon where the concentration of a drug is significantly reduced before it reaches systemic circulation
As can be observed in this larger cohort ( n = 45 group), long-term L2-Cmu treatment tended to reduce female body weight (Fig
Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals
As such, carnitine increases the use of fat as an energy source.
This is an important finding because it suggests that, unlike some medications where efficacy plateaus at maintenance dose, retatrutide may continue producing results with longer treatment duration
Approved by the FDA at the end of 2025 with a second product expected in April of this year, the oral GLP-1s are expected to open a new frontier for potential users including those hesitant to use injectable options